Many investors appear to be quite bearish Ariad Pharmaceuticals, Inc. (ARIA) especially if you look at the percentage of the float that is sold short for this stock. Currently, 24.6% of the float is sold short, suggesting an extreme level of bearishness for ARIA.

However, it is worth noting that earnings estimates have actually been moving higher for the company, despite the pessimism. Thanks to these rising estimates, we actually have a Zacks Rank #2(Buy) on ARIA, so we clearly don’t believe in the negativity surrounding this firm, and are instead looking for shares of ARIA to move higher in the weeks ahead.

 
ARIAD PHARMA (ARIA): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Ariad Charts.
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Ariad Charts.